woretaw  sisay

Mr. woretaw sisay

orcid
Lecturer and Researcher at Debre Tabor University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MZMulugeta Molla Zeleke
Mulugeta Molla Zeleke
woretaw  sisayworetaw sisay
woretaw sisay
YAYared Andargie
Yared Andargie
BKBelayneh Kefale
Belayneh Kefale
PSPradeep Singh
Pradeep Singh
Introduction: By measuring patients’ satisfaction, providers can gain insight into several elements of health care services, including the effectiveness of their care and the level of empathy they exhibit. The aim of this study was to assess patient satisfaction with pharmaceutical services and associated factors in public hospitals located in Northwestern Ethiopia. Methods: An institution-based quantitative cross-sectional study was used. The study was carried out in an outpatient pharmacy from January 1–June 30, 2021. Participants were selected by a systematic sampling technique. The IBM SPSS statistical package (version 23) was used to enter and analyze the collected data. The findings were presented using descriptive statistical methods. To find factors linked to satisfaction, binary logistic regression was used. Results: The final analysis included a total of 401 samples. More than half of the participants (229, or 55.1%) were female. The overall mean score of satisfaction was 30.6 out of a maximum of 100 scores. By taking this mean score as a cut-off point, 204 (50.9%) of the study participants had satisfaction with the outpatient pharmacists’ service. Participants’ responses scored on the uncomfortable and inconvenient waiting areas [AOR = 0.31; 95%CI, (0.13, 0.49)] were found to be negatively associated with the level of patients’ satisfaction. Also, the unavailability of medications [AOR = 0.12; 95%CI, (0.02, 0.37)] was negatively associated with the respondent satisfaction. Uncomfortable and inconvenient private counseling areas [AOR = 1.37; 95%CI, (0.79, 4.42)] showed a negative association with their satisfaction. Conclusion: Patients’ satisfaction levels with pharmacy service were found to be greater than 50%. The socio-demographic characteristics of patients have no association with their level of satisfaction, but their perception of uncomfortable private counseling areas and waiting areas was negatively associated with their satisfaction.

1 September 2020 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
PDF file
woretaw  sisayworetaw sisay
woretaw sisay
TATezera Jemere Aragaw
Tezera Jemere Aragaw
Background: Rumex nepalensis(RN) Spreng has been used to treat ulcer disease in Ethiopian folk medicine. This study aimed to determine the anti-ulcer activity of hydroalcoholic root crude extract and solvent fractions of R. nepalensis in rats. Methods: The effect of R. nepalensis crude hydromethanolic extract and solvent fractions at doses (100, 200, 400 mg/kg/day) and repeated dosing (200 mg/kg/day for 10 and 20 days) was examined on ulcers in rats in pyloric ligation-, cold restraint stress-, and acetic acid-induced ulcer models. Cimetidine (100 mg/kg/day) and/or Omeprazole (20 mg/kg/day) were used as standard drugs and served as a positive control. Data were analyzed by one-way ANOVA post hoc followed by a Tukey HSD test with SPSS software version 24.0, and P≤ 0.05 was considered as statistically significant. Results: In the pylorus ligation-induced ulcer model, pretreatment with the crude extract significantly reduced the degree of gastric secretions, pH, total acidity, and ulcerations in a dose-dependent manner. Gastroprotection offered by the R. nepalensis 400 mg/kg test extract was comparable to that of the standard. Among fractions, the ethyl acetate fraction at 400 mg/kg had the highest protection of ulcer but the chloroform fraction was ineffective. In the cold restraint stress-induced ulcer model, R. nepalensis at 200 and 400 mg/kg reduced the lesion index significantly (P< 0.01). With relevant chronic ulcer model treatment, a dose of R. nepalensis at 200 and 400 mg/kg healed ulcers significantly with a curative ratio of 53.22% and 54.59%, respectively. Conclusion: From this study, it is concluded that hydromethanolic crude extract and solvent fractions of R. nepalensis root showed promising anti-ulcer activity. This upholds its folkloric use. Thus, it is considered as a possible source to develop a new anti-ulcer agent.

20 July 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
woretaw  sisayworetaw sisay
woretaw sisay
YAYared Andargie
Yared Andargie
MMMulugeta Molla
Mulugeta Molla
ANAlefe Norahun
Alefe Norahun
Background. Urtica simensis has been used for the treatment of peptic ulcer disease in Ethiopian folkloric medicine by drinking its juice after boiling the semicrushed leaf. To our latest understanding, no in vivo study was available regarding its antiulcer activity. The present study was done to appraise the ulcer-protective and ulcer healing activity of hydromethanolic crude extract of leaf of U. simensis in rats. Methods. Preliminary qualitative phytochemical screening and oral acute toxicity were carried out using a standard protocol. To validate U. simensis in vivo antiulcer potential pyloric ligature, cold restraint stress and acetic acid-induced ulcer models were employed. The extracts (100, 200, and 400 mg per kg of body weight per day), standard treatment (omeprazole 20 mg/kg/day), and vehicle (distilled water 10 ml/kg/day) were given to treatment, positive, and negative controls by oral gavage, respectively. Parameters were then evaluated accordingly after the humane scarification of rats. Results. Any sign of toxicity was not observed in the oral acute toxicity test. The crude extracts exerted a significant ( ) inhibition of ulcer risk compared to the negative control. In the pylorus ligation-induced ulcer model, its antisecretory activity was in a dose-dependent manner. The highest gastroprotective effect (67.68%) was exhibited by the 400 mg/kg/day dose of 80% methanolic crude extract. Regarding the chronic ulcer model, treatment at a dosage of 100, 200, and 400 mg/kg/day cures ulcers by 33.54%, 58.33%, and 67.07%, respectively, as compared to the negative control groups remarkably. Conclusion. The findings of the present study confirmed the safety and a promising in vivo ulcer healing and antiulcerogenic activity of U. simensis, thus supporting the traditional claim. In-depth investigations on the plant, however, are highly recommended.

27 November 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YFYared Andargie Ferede
Yared Andargie Ferede
woretaw  sisayworetaw sisay
woretaw sisay
MZMulugeta Molla Zeleke
Mulugeta Molla Zeleke
MAMuluken Adela Alemu
Muluken Adela Alemu
Background. Diarrheal disease is a major cause of morbidity and mortality throughout the world, particularly in developing countries. Currently available drugs are linked with adverse effects, contraindications, and risk of resistance. Traditionally, the leaf concoction of Cordia africana is claimed to be used for diarrhea. However, the safety and efficacy of the leaf extract have not been scientifically approved yet. Therefore, the study was conducted to validate its antidiarrheal activity and safety profile in mice. Method. The hydromethanolic extract was obtained by the cold maceration technique in 80% methanol. Phytochemical screening tests were done for secondary metabolites by using standard tests. The antidiarrheal activity of the test extract at the doses of 100, 200, and 400 mg/kg was evaluated by using castor oil-induced diarrheal, gastrointestinal transit, and enteropooling models in mice. Result. In an acute toxicity study, there were no visible signs of toxicity and mortality following a single oral administration of 2000 mg/kg. Phytochemical screening tests revealed the presence of alkaloids, saponins, flavonoids, terpenoids, phenols, and tannins. The hydromethanolic extract significantly prolonged the onset of diarrhea and reduced the weight of wet and total feces at 100 ( ), 200 ( ), and 400 mg/kg ( ) in the castor oil-induced diarrheal model. However, in the gastrointestinal transit model, a significant ( ) reduction in the charcoal meal travel was observed in the middle (200 mg/kg) and higher (400 mg/kg) test doses. Similarly, the extract produced a significant ( ) reduction in the weight and volume of intestinal contents at the aforementioned doses. Conclusion. The study demonstrated that the test extract showed promising antidiarrheal activity. Hence, this study supports its antidiarrheal use in Ethiopian folklore medicine.

29 June 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YAYared Andargie
Yared Andargie
woretaw  sisayworetaw sisay
woretaw sisay
MZMulugeta Molla Zeleke
Mulugeta Molla Zeleke
ANAlefe Norahun
Alefe Norahun
PSPradeep Singh
Pradeep Singh
Introduction. In Ethiopia, traditionally, the leaves of Calpurnia aurea have been utilized to treat peptic ulcer disease. Therefore, the objective of the present study was to examine the antiulcer activity of Calpurnia aurea hydromethanolic leaf extract and solvent fractions in rats. Methods. The ulcer-healing potential of the crude test extract was assessed in rats by adopting pyloric ligation-, acidified ethanol-, and acetic acid-induced ulcer methods; while, in solvent fractions, the acidified ethanol-induced ulcer model was used. In all models, three serial test doses (100, 200, and 400 mg/kg) were given and the antiulcer activity was investigated. Standard drugs like sucralfate (100 mg/kg), omeprazole (20 mg/kg), and cimetidine (100 mg/kg) have been used as a positive control; whereas distilled water (10 mL/kg) was used as the negative control. Parameters like ulcer index, total acidity, pH, gastric volume, and gastric mucin level were all measured. Results. In an acute toxicity study, the test extract at the limit test dose (2 g/kg) was safe following a single dose administration. In pyloric ligation-induced ulcers, the plant extract at 200 and 400 mg/kg significantly reduced the ulcer index, the volume of stomach secretion, and total acidity while raising gastric pH and mucus content (P<0.05). Likewise, in the acidified ethanol- and acetic acid-induced ulcer models, the extract at both test doses (200 and 400 mg/kg) also displayed a substantial reduction (P<0.05) in ulcer index. Among the fractions, the ethyl acetate fraction revealed remarkable cytoprotective activity at all test doses and the aqueous fraction at 400 mg/kg (P<0.05). In contrast, the effect of chloroform fraction was found to be negligible. The peak ulcer inhibition was noted at 400 mg/kg of ethyl acetate fraction (52.4%). Conclusion. The study showed that the crude extract and solvent fractions possess remarkable antiulcer activity.

21 May 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
woretaw  sisayworetaw sisay
woretaw sisay
SDSamuel Berihun Dagnew
Samuel Berihun Dagnew
GTGetachew Yitayew Tarekegn
Getachew Yitayew Tarekegn
TYTaklo Simeneh Yazie
Taklo Simeneh Yazie
MAMeswait Asrat Ayicheh
Meswait Asrat Ayicheh
TMTilaye Arega Moges
Tilaye Arega Moges
Despite being crucial in ensuring the best treatment outcomes, adherence status is frequently overlooked in comprehensive chronic care. Thus, the present study critically evaluates, integrates, and summarizes psychotropic medication non-adherence and its determinants among patients with mental disorders in a resource limited life trajectories to inform policy and future research. Systematic review and meta-analysis following the Cochrane handbook for systematic reviews of interventions and Preferred Reporting Items for Systematic review and Meta-analysis (PRISMA) statement was conducted. PubMed (Medline), CINAHL, PsychINFO, EMBASE, and Google Scholar databases were comprehensively searched to retrieve published and grey literature from index inception to October 2024. Observational original studies focused on the magnitude of psychotropic treatment non-adherence and its predictors were eligible for inclusion. Risk-of-bias was assessed using Joanna Briggs Institute (JBI) criteria. Protocol was pre-registered at PROSPERO with a reference number of CRD42024578766. Twenty-three studies (n = 23, 359) were included, 22 of them in the quantitative analysis. The pooled prevalence of non-adherence was 46% (95% CI: 40%-52%, I2 = 96.95%). Subgroup analysis revealed that non-adherence was higher among patients with major depressive disorder (40.43%, I2 = 98.87%). Sociodemographic factors (aOR = 1.58, I2 = 87.13%), patient-related factors (aOR = 1.47, I2 = 25.62%), lack of insight (aOR = 1.24, I2 = 72.12%), negative attitude towards the treatment (aOR = 1.78, I2 = 0.00%), poor social support (aOR = 1.49, I2 = 82.55%), self-stigma (aOR = 1.97, I2 = 30.70%), and drug-related factors (aOR = 1.42, I2 = 64.16%) were the predictors. Substance use was identified as a protective factor for adherence (aOR = 0.84, I2 = 99.97%). Altogether, we discovered that psychotropic treatment non-adherence among patients with psychiatric disorders was quite common. This analysis may serve as a high-grade ore for policymakers, though it must be interpreted with caution due to significant heterogeneity. Notwithstanding stringent methodology, depending on cross-sectional studies limits its clinical guidance.